Latest News for: psma

Edit

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer (Form 6-K) (Novartis AG)

Public Technologies 28 Mar 2025
FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer ... that express PSMA, a transmembrane protein.
Edit

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer

PR Newswire 28 Mar 2025
0.29, 0.56; p<0.0001) compared to a change in ARPI in patients with PSMA-positive mCRPC after treatment with ARPI therapy ... "The clinical development of PSMA-targeting radioligand therapy has ...
Edit

Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate ...

Longview News-Journal 27 Mar 2025
- ATNM-400 is a novel, non-PSMA targeting, first-in-class Actinium-225 radiotherapy for prostate cancer with initial preclinical results to be presented at the AACR Annual Meeting ....
Edit

Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225

Longview News-Journal 27 Mar 2025
- 99.8% tumor growth inhibition achieved with a single dose of ATNM-400 in preclinical prostate cancer models ....
Edit

Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives

PR Newswire 27 Mar 2025
- ATNM-400 is a novel, non-PSMA targeting, first-in-class Actinium-225 radiotherapy for prostate cancer with initial preclinical results to be presented at the AACR Annual Meeting.
Edit

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Business Wire 26 Mar 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025 ... .
Edit

No shortage of sugar in country: PSMA

Urdu Point 25 Mar 2025
<p>LAHORE, (UrduPoint / Pakistan Point News - 25th Mar, 2025) Pakistan Sugar Mills Association (PSMA-Punjab Zone) spokesman has said that artificial price hike of sugar sponsored by Satta Mafia, ...
Edit

PSMA rejects price-hike link to exports

Urdu Point 21 Mar 2025
<p>LAHORE, (UrduPoint / Pakistan Point News - 21st Mar, 2025) The Pakistan Sugar Mills Association (PSMA-Punjab Zone) has refuted claims that sugar exports are responsible for rising prices, ...
Edit

Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in The Netherlands (Telix Pharmaceuticals Ltd)

Public Technologies 18 Mar 2025
This approval enables healthcare providers in the Netherlands to offer PSMA-PET[3] imaging using a clinically validated gallium-based radiopharmaceutical ... Telix provided Illuccix® (TLX591-CDx) for PSMA-PET imaging.
  • 1
×